Terms: = Germ cell tumor AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Treatment
201 results:
1. Differential tractography and whole brain connectometry in primary motor area gliomas resection: A feasibility study.
Figueredo LF; Mejía-Cordovez JA; Gomez-Amarillo DA; Hakim F; Pimienta-Redondo HD; Almeida JP; Kehayov I; Angelova P; Apostolov G; Luzzi S; Baldoncini M; Johnson JM; Ordóñez-Rubiano EG
Clin Neurol Neurosurg; 2024 Jun; 241():108305. PubMed ID: 38713964
[TBL] [Abstract] [Full Text] [Related]
2. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract] [Full Text] [Related]
3. Exploration of the photothermal role of curcumin-loaded targeted carbon nanotubes as a potential therapy for melanoma cancer.
Kargar B; Fazeli M; Sobhani Z; Hosseinzadeh S; Solhjoo A; Akbarizadeh AR
Sci Rep; 2024 May; 14(1):10117. PubMed ID: 38698033
[TBL] [Abstract] [Full Text] [Related]
4. germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
5. High OXPHOS efficiency in RA-FUdr-differentiated SH-SY5Y cells: involvement of cAMP signalling and respiratory supercomplexes.
Matrella ML; Valletti A; Gigante I; De Rasmo D; Signorile A; Russo S; Lobasso S; Lobraico D; Dibattista M; Pacelli C; Cocco T
Sci Rep; 2024 Mar; 14(1):7411. PubMed ID: 38548913
[TBL] [Abstract] [Full Text] [Related]
6. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
Liu HM; Zhang Y
Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
[TBL] [Abstract] [Full Text] [Related]
7. Preparation and Evaluation of Folate Modified PEG-PLLA Nanoparticles Loaded with Lycorine for Glioma treatment.
Ding J; Su J; Luo B; Ding L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474593
[TBL] [Abstract] [Full Text] [Related]
8. Alterations in Plasma Lipid Profiles Associated with Melanoma and Therapy Resistance.
Dei Cas M; Ciniselli CM; Vergani E; Ciusani E; Aloisi M; Duroni V; Verderio P; Ghidoni R; Paroni R; Perego P; Beretta GL; Gatti L; Rodolfo M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338838
[TBL] [Abstract] [Full Text] [Related]
9. Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs.
Cheng J; Xie W; Chen Y; Sun Y; Gong L; Wang H; Li C; Zhang Y
Drug Resist Updat; 2024 Mar; 73():101056. PubMed ID: 38277755
[TBL] [Abstract] [Full Text] [Related]
10. Folic Acid-Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma.
Zhang D; Zhang M; Pang Y; Li M; Ma W
ACS Biomater Sci Eng; 2024 Jan; 10(1):588-598. PubMed ID: 38117929
[TBL] [Abstract] [Full Text] [Related]
11. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract] [Full Text] [Related]
12. Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid?
Marchesi N; Linciano P; Campagnoli LIM; Fahmideh F; Rossi D; Costa G; Ambrosio FA; Barbieri A; Collina S; Pascale A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569576
[TBL] [Abstract] [Full Text] [Related]
13. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO
Uribe-Robles M; Ortiz-Islas E; Rodriguez-Perez E; Valverde FF; Lim T; Martinez-Morales AA
Biomater Adv; 2023 Aug; 151():213442. PubMed ID: 37207587
[TBL] [Abstract] [Full Text] [Related]
14. tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
Fishman H; Monin R; Dor-On E; Kinzel A; Haber A; Giladi M; Weinberg U; Palti Y
J Neurooncol; 2023 May; 163(1):83-94. PubMed ID: 37131108
[TBL] [Abstract] [Full Text] [Related]
15. Targeting fatty acid metabolism in glioblastoma.
Miska J; Chandel NS
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594473
[TBL] [Abstract] [Full Text] [Related]
16. Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
Kamali M; Webster TJ; Amani A; Hadjighassem MR; Malekpour MR; Tirgar F; Khosravani M; Adabi M
Life Sci; 2023 Jan; 313():121248. PubMed ID: 36526047
[TBL] [Abstract] [Full Text] [Related]
17. Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia.
Parker VL; Cushen BF; Hills A; Kandiah K; Palmer JE; Singh K; Hancock BW; Tidy JA; Winter MC
Gynecol Oncol; 2023 Feb; 169():34-40. PubMed ID: 36495594
[TBL] [Abstract] [Full Text] [Related]
18. Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation.
Umaru BA; Kagawa Y; Ohsaki Y; Pan Y; Chen CT; Chen DK; Abe T; Shil SK; Miyazaki H; Kobayashi S; Maekawa M; Yamamoto Y; Wannakul T; Yang S; Bazinet RP; Owada Y
FEBS J; 2023 Apr; 290(7):1798-1821. PubMed ID: 36325660
[TBL] [Abstract] [Full Text] [Related]
19. Combined treatment with Curcumin and Ferulic Acid Suppressed the Aβ-Induced Neurotoxicity More than Curcumin and Ferulic Acid Alone.
Ohashi H; Tsuji M; Oguchi T; Momma Y; Nohara T; Ito N; Yamamoto K; Nagata M; Kimura AM; Kiuchi Y; Ono K
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077082
[TBL] [Abstract] [Full Text] [Related]
20. Imaging of spinal chordoma and benign notochordal cell tumor (BNCT) with radiologic pathologic correlation.
Murphey MD; Minn MJ; Contreras AL; Koeller KK; Shih RY; Inwards CY; Yamaguchi T
Skeletal Radiol; 2023 Mar; 52(3):349-363. PubMed ID: 36063190
[TBL] [Abstract] [Full Text] [Related]
[Next]
